Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Winget

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Pharmaceutical Education|January 14, 2022
A Practical Review of Mastery LearningMarshall Winget, Adam M Persky
Clinical Rheumatology|July 26, 2024
Infection prophylaxis among patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis: a scoping reviewBinxin Cao, Jacob E Robinson, Marshall Winget, et al.
Journal of Pain and Symptom Management|April 20, 2026
Real-World Experience with Initiating Buprenorphine in Opioid Tolerant Patients with Cancer PainOlivia Idom, Marshall Winget, Amanda Toye, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Pharmaceutical Education|January 14, 2022
A Practical Review of Mastery LearningMarshall Winget, Adam M Persky
Clinical Rheumatology|July 26, 2024
Infection prophylaxis among patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis: a scoping reviewBinxin Cao, Jacob E Robinson, Marshall Winget, et al.
Journal of Pain and Symptom Management|April 20, 2026
Real-World Experience with Initiating Buprenorphine in Opioid Tolerant Patients with Cancer PainOlivia Idom, Marshall Winget, Amanda Toye, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.
Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Pageof 1